• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Congressman Frank Pallone, Jr, on Expediting the FDA Drug Approval Process

Video

Funding from the 21st Century Cures Act to the FDA will help expedite the drug approval process without sacrificing the accountability and effectiveness of the FDA's standards, said Congressman Frank Pallone, Jr (D-NJ).

In addition to funding for the Nationa Institutes of Health, the 21st Century Cures Act grants $550 million to the FDA for research and innovation specifically for drugs and medical devices, said Congressman Frank Pallone, Jr (D-NJ).

He believes that while this initiative expedite the process for a number of programs and clinical trials, it will maintain the accountability and effectiveness of the FDA’s standards.

“I was at the European Union about a month ago talking to the equivalent of the FDA in the European Union in Brussels and we’re the gold standard,” Mr Pallone said. “We’re the most rigorous process there is for both drugs and medical devices and I think that there are ways that maybe you can streamline that without limiting effectiveness.”

Related Videos
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Dr Chris Pagnani
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Alexander Kutikov, MD, during a video interview
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.